{
    "nctId": "NCT01754597",
    "briefTitle": "Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines",
    "officialTitle": "Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines. Pilot Study in Patients Operated on for Breast Cancer. Monocentric Study Feasibility.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 56,
    "primaryOutcomeMeasure": "Describe the evolution of the concentrations of NT-proBNP, through repeated dosing during general anesthesia in patients operated on for breast cancer and anthracycline-sensitized or not",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women over 18 years with effective contraceptive method (if applicable)\n* NT-proBNP \\<125 pg / ml\n* ASA 1 or 2,\n* Breast cancer histologically proven\n* Mastectomy or lumpectomy\n* Neoadjuvant chemotherapy with anthracyclines in 6 months or received no chemotherapy with anthracyclines,\n* Patients who received the briefing and signed the informed consent\n* Patients affiliated to a social security system.\n\nExclusion Criteria:\n\n* Patients for whom the maintenance of general anesthesia does not use halogenated.\n* Renal impairment: Creatinine clearance \\<60 ml / min,\n* Patients who for reasons psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study, patients deprived of liberty or under guardianship.\n* Presence of a cardiopathy\n* Pregnant Women",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}